パーブル・バイオテックのニュース一覧

Purple Biotech Shares Resume Trade

Benzinga12/06 00:32

Purple Biotech Shares Halted On Circuit Breaker To The Downside, Stock Now Down -29.2%

Benzinga12/06 00:29

Purple Biotech Shares Are Trading Lower After the Company Announced a $2.8 Million Offering of 472,688 ADS.

Benzinga12/05 04:37

PPBT Stock Surges 150% on Superior Efficacy of PDAC Combo Therapy

Zacks 12/03 23:35

Why Purple Biotech (PPBT) Stock Is Getting Hammered

Benzinga12/03 22:30

Purple Biotech Announces $2.8M Offering Of 472,668 ADS.

Benzinga12/03 21:26

ADRs Advance; Purple Biotech Ltd. Climbs 150%

Dow Jones12/03 05:31

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga12/03 05:05

Purple Biotech Shares Halted On Circuit Breaker To The Upside, Stock Now Up 86.9%

Benzinga12/02 23:16

Economic Data in Focus as US Equity Futures Waver Pre-Bell

MT Newswires12/02 22:13

Purple Biotech Shares Jump on Positive Phase 2 Cancer Drug Study Results

WSJ12/02 21:49

Top Premarket Gainers

MT Newswires12/02 20:37

Purple Biotech Reported Final Results From Phase 2 Study Of Its Lead Oncology Drug, CM24, In Patients With Pancreatic Ductal Adenocarcinoma

Benzinga12/02 20:15

HC Wainwright & Co. Reiterates Buy on Purple Biotech, Maintains $33 Price Target

Benzinga11/16 03:44

Purple Biotech Reports Q3 Basic And Diluted Loss Per ADS Of $0.39, Exits Quarter With Cash & Equivalents Worth $5.438M

Benzinga11/15 20:08

Purple Biotech: Cash Runway Into 4Q 2025 >PPBT

Dow Jones11/15 20:01

Purple Biotech 3Q Loss/Shr 39c >PPBT

Dow Jones11/15 20:01

Press Release: Purple Biotech Reports Third Quarter 2024 Financial Results

Dow Jones11/15 20:00

Purple Biotech Identifies Potential New Serum Biomarker For Its Lead Oncology Therapeutic Candidate CM24: Associated With 79% Reduction In Risk Of Death

Benzinga11/04 21:00

12 Health Care Stocks Moving In Friday's After-Market Session

Benzinga11/02 04:36